Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 0115-3911-02 - (CARBIDOPA and LEVODOPA)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 0115-3911
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: CARBIDOPA and LEVODOPA
Active Ingredient(s): 50; 200    mg/1; mg/1 & nbsp;   CARBIDOPA and LEVODOPA
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 0115-3911
Labeler Name: Global Pharmaceuticals, Division of Impax Laboratories Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076521
Marketing Category: ANDA
Start Marketing Date: 20040514

Package Information of Carbidopa and Levodopa

Package NDC: 0115-3911-02
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-3911-02)

NDC Information of Carbidopa and Levodopa

NDC Code 0115-3911-02
Proprietary Name Carbidopa and Levodopa
Package Description 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-3911-02)
Product NDC 0115-3911
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CARBIDOPA and LEVODOPA
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20040514
Marketing Category Name ANDA
Labeler Name Global Pharmaceuticals, Division of Impax Laboratories Inc.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 50; 200
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information